by The bio decontamination market is estimated to be valued at US$ 178.3 Mn or Mn in 2023 and is expected to exhibit a CAGR of 18.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bio decontamination refers to sterilization and disinfection processes that neutralize or remove biological contaminants from enclosed facilities, rooms, or chambers using gaseous decontaminants, vaporous hydrogen peroxide. It helps eliminate harmful pathogens like viruses, bacteria, and spores. Key end users of bio decontamination include life sciences industry, healthcare facilities, pharmaceutical companies etc.
Market Dynamics:
Rising prevalence of hospital-acquired infections (HAIs) and growing healthcare regulations regarding decontamination of facilities are the primary factors driving growth of the global bio decontamination market. Additionally, increasing outsourcing of bio decontamination services to specialized companies is also expected to boost demand over the forecast period. Furthermore, technological advancements leading to development of improved and efficient bio decontamination systems are further expected to support market growth. However, high installation and maintenance costs of bio decontamination systems may hamper market growth.
SWOT Analysis
Strength: The bio decontamination market is driven by three main strengths – its ability to inactivate microorganisms quickly, ensure safety of people and environments, and reduce sterilization time.
Weakness: Two main weaknesses are its high capital investment requirements and operational costs of equipment maintenance. Performing decontamination also requires halting production lines.
Opportunity: Growth in pharmaceutical and biotechnology industries relying on clean rooms presents an opportunity. Rapid response decontamination services after biohazards also offer opportunities.
Threats: Stringent regulations raise compliance costs which threaten smaller players. New contamination threats pose challenges for technologies to address effectively in short timeframes.
Key Takeaways
The Global Bio Decontamination Market Growth is expected to witness high, exhibiting a CAGR of 18% over the forecast period, due to increasing safety concerns in the healthcare industry. End users such as pharmaceutical and biotech companies extensively use bio decontamination equipment to eliminate microbes from manufacturing facilities and ensure the sterility of drugs.
Regional analysis: North America dominates the global bio decontamination market currently. This is attributed to stringent regulatory mandates for sterilization in the healthcare industry. Asia Pacific is expected to grow at the fastest pace during the forecast period due to increasing penetration of contract sterilization companies catering to major global pharmaceutical companies setting up manufacturing units in countries such as India and China.
Key players: Key players operating in the bio decontamination market are STERIS Corporation, Ecolab, Inc., TOMI Environmental Solutions, Inc., JCE Biotechnology, Fedegari Autoclavi SpA, Howorth Air Technology Ltd., Noxilizer, Inc., ClorDiSys Solutions, Inc., Wenzhou Weike Biological Laboratory Equipment Co., Ltd. Rising safety awareness is driving these players to introduce advanced technologies for decontamination of healthcare facilities in a short timeframe with minimal operational disruptions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.
